Share data
30/04/2025
China Traditional Chinese Medicine Holdings Co. Limited is the core modern TCM platform by China National Pharmaceutical Group Co., Ltd. The Company (stock code: 00570.HK) is listed on the Main Board of the Hong Kong Stock Exchange. Headquartered in Foshan, Guangdong. With "implement the national development strategies of TCM to lead the high-quality development of TCM industry"as the mission, the Company establishes the largest TCM manufacturing industry cluster in China, and its business integrates five segments: Chinese medicinal herbs integration business, TCM decoction pieces, concentrated TCM granules, TCM finished drugs, TCM great health.
Currency | HKD |
Previous Close | 2.02 |
Change (%) | 0.50 |
Volume | 20,528,911 |
Number of Shares | 5,035,801,852 |
Market Cap (mln) | 10,172 |
Financial Highlights, RMB'000 | 2022 | 2023 | 2024 |
Results | |||
Revenue | 14,304,242 | 18,121,861 | 16,509,708 |
Gross profit | 7,198,452 | 9,274,492 | 7,856,308 |
Profit from operations | 1,064,283 | 1,427,277 | 335,594 |
Profit before taxation | 840,109 | 1,224,533 | 163,109 |
Profit attributable to the shareholders of the Company | 764,486 | 1,285,200 | 54,067 |
Profitability | |||
Gross profit margin (%) | 50.32 | 51.18 | 47.59 |
Operating profit margin (%) | 7.44 | 7.88 | 2.03 |
Net profit margin (%) | 5.04 | 7.70 | 0.13 |
Earnings per share | |||
Basic & Diluted (cents) | 15.18 | 25.52 | 1.07 |
Financial Position | |||
Total assets | 35,636,977 | 37,068,348 | 35,063,718 |
Total equity attributable to equity shareholders of the Company | 20,168,127 | 21,160,135 | 21,203,784 |
Total liabilities | 12,688,862 | 13,131,730 | 11,130,684 |
Cash and cash equivalents | 3,065,054 | 3,017,318 | 3,866,911 |
Debt asset ratio (%) | 35.61 | 35.43 | 31.74 |